Skip to main content

Advertisement

SpringerLink
Log in

Adoptive T cell immunotherapy of MSV-induced tumours in nude mice. Part l. Biology of tumour regression and recurrence

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

The induction of immunity to progressively growing murine sarcoma virus (MSV) tumours in nude (nu/nu) mice by reconstitution with immune T cells from syngeneic (+/+) donors has been studied. Whole spleen cell preparations served as the source of immune T cells. Transfer of immune, but not of normal, spleen cells resulted in partial or apparently complete regression of primary tumours and a related moderate to considerable extension of survival time. The dose, the time in days between immunization and transfer, as well as timing of the spleen cells in relation to tumour cell challenge, were all factors which influenced the effectiveness of the protective inocula. An unexpected consequence of even the very effective primary immunotherapy regimens, was secondary tumour development after varying tumour-free intervals. This was most frequently manifest as tumour recurrences at the original injection site either on their own or in combination with distant metastases. Such a relatively high frequency of tumour reappearance and metastatic spread contrasts markedly with the rare instances of secondary regrowth in normal immunocompetent mice. The present reconstitution system may therefore provide a new model for studying the inhibitory or stimulatory properties of T cells with respect to tumour regression and dissemination.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

nu/nu:

Homozygous nude mice on a BALB/c background

+/+:

Homozygous normal BALB/c mice

SPF:

Specific pathogen free

CR:

Complete regression of primary tumour

References

  1. Allison, A. C., Marga, J. N., andHammond, V., 1974, Increased susceptibility to virus oncogenesis in congenitally thymus-deprived nude mice.Nature, London,252, 746–747.

    Google Scholar 

  2. Collavo, D., Colombatti, A., Biasi, G., Chieco-Bianchi, L., andDavies, A. J. S., 1976, Immune reactivity in the Moloney strain of Murine Sarcoma virus oncogenesis; requirement of thymus-derived lymphocytes forvivo protection.Journal of the National Cancer Institute,56, 603–608.

    Google Scholar 

  3. Davis, S., 1975, Moloney sarcoma virus-induced tumours in athymic (nude) mice growth pattern and antibody responses.Journal of the National Cancer Institute,54, 793–794.

    Google Scholar 

  4. de Clerq, E., 1975, Tumour induction by Moloney sarcoma virus in athymic nude mice.Journal of the National Cancer Institute,54, 473–477.

    Google Scholar 

  5. Fefer, A., McCoy, J. L., Perk, K., andGlynn, J. P., 1968, Immunologic, virologic, and pathologic studies of regression of autochthonous Moloney sarcoma virus-induced tumours in mice.Cancer Research,28, 1577–1585.

    Google Scholar 

  6. Fidler, I. J., Gersten, D. M., andRiggs, C. W., 1977, Quantitative analysis of tumor-host interaction and the outcome of experimental metastasis. In:Cancer Invasion and Metastasis: Biologic mechanisms and therapy, edited by S. B. Day (New York: Raven Press), pp. 277–303.

    Google Scholar 

  7. Glantz, S. A., 1981, In:Printer of Biostatistics. edited by R. S. Lanfer and T. K. Geno (New York: McGraw-Hill Book Company), p. 273.

    Google Scholar 

  8. Gorczynski, R. M., 1974, Evidence forin vivo protection against murine sarcoma virus-induced tumors by T lymphocytes from immune animals.Journal of Immunology,112, 533–539.

    Google Scholar 

  9. Gorczynski, R. M., andKnight, R. A., 1975, Cell-mediated immunity to Moloney sarcoma virus in mice. II. Analysis of antigenic specificies involved in T lymphocyte-mediatedin vivo rejection of murine sarcoma virus (MSV)-induced tumours.European Journal of Immunology,5, 148–155.

    Google Scholar 

  10. Gordon, J., Holden, H. T., Segal, S., andFeldman, M., 1982, Anti-tumor immunity in B-lymphocyte-deprived mice. III. Immunity to primary Moloney sarcoma virus-induced tumours.International Journal of Cancer,29, 351–357.

    Google Scholar 

  11. Harvey, J., andEast, J., 1971, The murine sarcoma virus (MSV).International Review of Experimental Pathology, 10, 265–360.

    Google Scholar 

  12. Holden, H. T., Haskill, J. S., Kirchner, H., andHerberman, R. B., 1976, Two functionally distinct anti-tumor effector cells isolated from primary murine sarcoma virus-induced tumors.Journal of Immunology,117, 440–446.

    Google Scholar 

  13. Knight, R. A., andGorczynski, R. M., 1975, Cell-mediated immunity to Moloney sarcoma virus in mice. I. Analysis of antigens responsible for lymphocyte stimulation in regressor mice.International Journal of Cancer,15, 48–58.

    Google Scholar 

  14. Leclerc, J. C., andCantor, H., 1980, T cell-mediated immunity to oncornavirus-induced tumors. II. Ability of different T cell sets to prevent tumour growthin vivo.Journal of Immunology,124, 851–854.

    Google Scholar 

  15. Lerc J. C., andGomard, E., Unpublished, cited in [17].

  16. Leclerc, J. C., Gomard, E., andLevy, J. P., 1972, Cell-mediated reaction against tumours induced by oncornaviruses. I. Kinetics and specificity of the immune response in murine sarcoma virus (MSV)-induced tumours and transplanted lymphomas.International Journal of Cancer,10, 589–601.

    Google Scholar 

  17. Levy, J. P., andLeclerc, J. C., 1977, The murine sarcoma virus-induced tumor: exception or general model in tumor immunology?Advances in Cancer Research,24, 1–66.

    Google Scholar 

  18. Perk, K., andMoloney, J. B., 1966, Pathogenesis of a virus-induced rhabdomyosarcoma in mice.Journal of the National Cancer Institute,37, 581–599.

    Google Scholar 

  19. Plata, F., Cerottini, J. C., andBrunner, K. T., 1975, Primary and secondaryin vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system.European Journal of Immunology,5, 227–233.

    Google Scholar 

  20. Prehn, R. T., andLappe, M. A., 1971, An immunostimulation theory of tumour development.Transplantation Reviews,7, 26–54.

    Google Scholar 

  21. Skov, C. B., Hollant, J. M., andPerkins, E. M., 1976, Development of fewer tumor colonies in the lungs of athymic mice after intravenous injection of tumor cells.Journal of the National Cancer Institute,56, 193–195.

    Google Scholar 

  22. Steel, G. G., 1977, Growth rate of tumours. In:Growth Kinetics of Tumours (Oxford: Clarendon Press), p. 5.

    Google Scholar 

  23. Stutman, O., 1974, Immunodepression and malignancy. In:Proceedings of the 11th International Cancer Congress 1, edited by P. Bucalossi, U. Veronesi and N. Cascinelli (Excerpts Medica), pp. 275–279.

  24. Stutman, O., 1975, Delayed tumour appearance and absence of regression in nude mice infected with murine sarcoma virus.Nature, London,253, 142–144.

    Google Scholar 

  25. Taniyania, T., andHolden, H. T., 1979, Cytolytic activity of macrophages isolated from primary murine sarcoma virus (MSV)-induced tumours.International Journal of Cancer,24, 151–160.

    Google Scholar 

  26. Tucker, D. F., Knight, R. A., andWarne, P. H., 1983, Adoptive T cell immunotherapy of MSV-induced tumours in nude mice. Part II. Sequential analysis of serum immune complexes and blocking activity in reconstituted mice in relation to tumour biology.Clinical and Experimental Metastasis,1, 275.

    Google Scholar 

  27. Varet, B., Levy, J. P., Leclerc, J. C., andSenik, A., 1968, The role of immunity in the rejection of tumors induced by the MSV virus. The effect of antithymocyte serums.International Journal of Cancer,3, 727–733.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory for Immunological Markers in Cancer, Imperial Cancer Research Fund Laboratories, WC2A 3PX, Lincoln's Inn Fields, London

    D. F. Tucker & Patricia H. Warne

  2. Tumour Immunology Unit, Imperial Cancer Research Fund Laboratories, WC2A 3PX, Lincoln's Inn Fields, London

    R. A. Knight

Authors
  1. D. F. Tucker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. A. Knight
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patricia H. Warne
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tucker, D.F., Knight, R.A. & Warne, P.H. Adoptive T cell immunotherapy of MSV-induced tumours in nude mice. Part l. Biology of tumour regression and recurrence. Clin Exp Metast 1, 261–273 (1983). https://doi.org/10.1007/BF00736409

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00736409

Keywords

Search

Navigation